These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21134077)

  • 61. A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer.
    Burger AM; Gao Y; Amemiya Y; Kahn HJ; Kitching R; Yang Y; Sun P; Narod SA; Hanna WM; Seth AK
    Cancer Res; 2005 Nov; 65(22):10401-12. PubMed ID: 16288031
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinoma.
    Goeppert B; Ernst C; Baer C; Roessler S; Renner M; Mehrabi A; Hafezi M; Pathil A; Warth A; Stenzinger A; Weichert W; Bähr M; Will R; Schirmacher P; Plass C; Weichenhan D
    Epigenetics; 2016 Nov; 11(11):780-790. PubMed ID: 27593557
    [TBL] [Abstract][Full Text] [Related]  

  • 63. FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma.
    Park MJ; Taki T; Oda M; Watanabe T; Yumura-Yagi K; Kobayashi R; Suzuki N; Hara J; Horibe K; Hayashi Y
    Br J Haematol; 2009 Apr; 145(2):198-206. PubMed ID: 19245433
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prevention of cancer dormancy by Fbxw7 ablation eradicates disseminated tumor cells.
    Shimizu H; Takeishi S; Nakatsumi H; Nakayama KI
    JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830867
    [TBL] [Abstract][Full Text] [Related]  

  • 65. FBXW7 regulates glucocorticoid response in T-cell acute lymphoblastic leukaemia by targeting the glucocorticoid receptor for degradation.
    Malyukova A; Brown S; Papa R; O'Brien R; Giles J; Trahair TN; Dalla Pozza L; Sutton R; Liu T; Haber M; Norris MD; Lock RB; Sangfelt O; Marshall GM
    Leukemia; 2013 Apr; 27(5):1053-62. PubMed ID: 23228967
    [TBL] [Abstract][Full Text] [Related]  

  • 66. RNAi screen reveals synthetic lethality between cyclin G-associated kinase and FBXW7 by inducing aberrant mitoses.
    Dolly SO; Gurden MD; Drosopoulos K; Clarke P; de Bono J; Kaye S; Workman P; Linardopoulos S
    Br J Cancer; 2017 Sep; 117(7):954-964. PubMed ID: 28829765
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The role of FBXW7, a cell-cycle regulator, as a predictive marker of recurrence of gastrointestinal stromal tumors.
    Koga Y; Iwatsuki M; Yamashita K; Kiyozumi Y; Kurashige J; Masuda T; Eto K; Iwagami S; Harada K; Ishimoto T; Baba Y; Yoshida N; Miyanari N; Takamori H; Ajani JA; Baba H
    Gastric Cancer; 2019 Nov; 22(6):1100-1108. PubMed ID: 30854619
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer.
    Ekholm-Reed S; Spruck CH; Sangfelt O; van Drogen F; Mueller-Holzner E; Widschwendter M; Zetterberg A; Reed SI
    Cancer Res; 2004 Feb; 64(3):795-800. PubMed ID: 14871801
    [TBL] [Abstract][Full Text] [Related]  

  • 69.
    Qiao X; Liu Y; Prada ML; Mohan AK; Gupta A; Jaiswal A; Sharma M; Merisaari J; Haikala HM; Talvinen K; Yetukuri L; Pylvänäinen JW; Klefström J; Kronqvist P; Meinander A; Aittokallio T; Hietakangas V; Eilers M; Westermarck J
    Cancer Res; 2020 Apr; 80(7):1414-1427. PubMed ID: 32029551
    [TBL] [Abstract][Full Text] [Related]  

  • 70. SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients.
    Song GD; Sun Y; Shen H; Li W
    Tumour Biol; 2015 Jun; 36(6):4167-73. PubMed ID: 25592378
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Promoter hypermethylation is not the major mechanism for inactivation of the FBXW7 beta-form in human gliomas.
    Gu Z; Inomata K; Mitsui H; Horii A
    Genes Genet Syst; 2008 Aug; 83(4):347-52. PubMed ID: 18931460
    [TBL] [Abstract][Full Text] [Related]  

  • 72. KNSTRN Is a Prognostic Biomarker That Is Correlated with Immune Infiltration in Breast Cancer and Promotes Cell Cycle and Proliferation.
    Zhang W; Xiao Y; Zhou Q; Zhu X; Zhang Y; Xiang Q; Wu S; Song X; Zhao J; Yuan R; Xiao B; Li L
    Biochem Genet; 2024 Oct; 62(5):3709-3739. PubMed ID: 38198023
    [TBL] [Abstract][Full Text] [Related]  

  • 73. High expression of valosin-containing protein predicts poor prognosis in patients with breast carcinoma.
    Cui Y; Niu M; Zhang X; Zhong Z; Wang J; Pang D
    Tumour Biol; 2015 Dec; 36(12):9919-27. PubMed ID: 26168958
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The clinical and prognostic significance of midkine in breast cancer patients.
    Li F; Tian P; Zhang J; Kou C
    Tumour Biol; 2015 Dec; 36(12):9789-94. PubMed ID: 26159850
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The pseudophosphatase STYX targets the F-box of FBXW7 and inhibits SCFFBXW7 function.
    Reiterer V; Figueras-Puig C; Le Guerroue F; Confalonieri S; Vecchi M; Jalapothu D; Kanse SM; Deshaies RJ; Di Fiore PP; Behrends C; Farhan H
    EMBO J; 2017 Feb; 36(3):260-273. PubMed ID: 28007894
    [TBL] [Abstract][Full Text] [Related]  

  • 76. MicroRNA-10b and minichromosome maintenance complex component 5 gene as prognostic biomarkers in breast cancer.
    Eissa S; Matboli M; Shehata HH; Essawy NO
    Tumour Biol; 2015 Jun; 36(6):4487-94. PubMed ID: 25596707
    [TBL] [Abstract][Full Text] [Related]  

  • 77. High expression of FOXR2 in breast cancer correlates with poor prognosis.
    Song H; He W; Huang X; Zhang H; Huang T
    Tumour Biol; 2016 May; 37(5):5991-7. PubMed ID: 26596836
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The methylation status of FBXW7 beta-form correlates with histological subtype in human thymoma.
    Gu Z; Mitsui H; Inomata K; Honda M; Endo C; Sakurada A; Sato M; Okada Y; Kondo T; Horii A
    Biochem Biophys Res Commun; 2008 Dec; 377(2):685-688. PubMed ID: 18938137
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer.
    Hu Z; Huang G; Sadanandam A; Gu S; Lenburg ME; Pai M; Bayani N; Blakely EA; Gray JW; Mao JH
    Breast Cancer Res; 2010; 12(2):R18. PubMed ID: 20211017
    [TBL] [Abstract][Full Text] [Related]  

  • 80. TRIP-Br links E2F to novel functions in the regulation of cyclin E expression during cell cycle progression and in the maintenance of genomic stability.
    Sim KG; Zang Z; Yang CM; Bonventre JV; Hsu SI
    Cell Cycle; 2004 Oct; 3(10):1296-304. PubMed ID: 15467469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.